Literature DB >> 24925083

Inference about the expected performance of a data-driven dynamic treatment regime.

Bibhas Chakraborty1, Eric B Laber2, Ying-Qi Zhao3.   

Abstract

BACKGROUND: A dynamic treatment regime (DTR) comprises a sequence of decision rules, one per stage of intervention, that recommends how to individualize treatment to patients based on evolving treatment and covariate history. These regimes are useful for managing chronic disorders, and fit into the larger paradigm of personalized medicine. The Value of a DTR is the expected outcome when the DTR is used to assign treatments to a population of interest.
PURPOSE: The Value of a data-driven DTR, estimated using data from a Sequential Multiple Assignment Randomized Trial, is both a data-dependent parameter and a non-smooth function of the underlying generative distribution. These features introduce additional variability that is not accounted for by standard methods for conducting statistical inference, for example, the bootstrap or normal approximations, if applied without adjustment. Our purpose is to provide a feasible method for constructing valid confidence intervals (CIs) for this quantity of practical interest.
METHODS: We propose a conceptually simple and computationally feasible method for constructing valid CIs for the Value of an estimated DTR based on subsampling. The method is self-tuning by virtue of an approach called the double bootstrap. We demonstrate the proposed method using a series of simulated experiments.
RESULTS: The proposed method offers considerable improvement in terms of coverage rates of the CIs over the standard bootstrap approach. LIMITATIONS: In this article, we have restricted our attention to Q-learning for estimating the optimal DTR. However, other methods can be employed for this purpose; to keep the discussion focused, we have not explored these alternatives.
CONCLUSION: Subsampling-based CIs provide much better performance compared to standard bootstrap for the Value of an estimated DTR.
© The Author(s), 2014.

Entities:  

Year:  2014        PMID: 24925083      PMCID: PMC4265005          DOI: 10.1177/1740774514537727

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  42 in total

1.  Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.

Authors:  Jared K Lunceford; Marie Davidian; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Weighted Kaplan-Meier estimators for two-stage treatment regimes.

Authors:  Sachiko Miyahara; Abdus S Wahed
Journal:  Stat Med       Date:  2010-11-10       Impact factor: 2.373

3.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

4.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

5.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

Review 6.  A "SMART" design for building individualized treatment sequences.

Authors:  H Lei; I Nahum-Shani; K Lynch; D Oslin; S A Murphy
Journal:  Annu Rev Clin Psychol       Date:  2011-12-12       Impact factor: 18.561

7.  Adaptive interventions may optimize outcomes in drug courts: a pilot study.

Authors:  Douglas B Marlowe; David S Festinger; Patricia L Arabia; Karen L Dugosh; Kathleen M Benasutti; Jason R Croft
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

8.  Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.

Authors:  Peter F Thall; Christopher Logothetis; Lance C Pagliaro; Sijin Wen; Melissa A Brown; Dallas Williams; Randall E Millikan
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506

9.  New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Authors:  Ying-Qi Zhao; Donglin Zeng; Eric B Laber; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2015       Impact factor: 5.033

10.  Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.

Authors:  Lu Wang; Andrea Rotnitzky; Xihong Lin; Randall E Millikan; Peter F Thall
Journal:  J Am Stat Assoc       Date:  2012-06       Impact factor: 5.033

View more
  12 in total

1.  Comment.

Authors:  Qian Guan; Eric B Laber; Brian J Reich
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

2.  Evaluating the impact of treating the optimal subgroup.

Authors:  Alexander R Luedtke; Mark J van der Laan
Journal:  Stat Methods Med Res       Date:  2017-05-08       Impact factor: 3.021

3.  Precision Medicine.

Authors:  Michael R Kosorok; Eric B Laber
Journal:  Annu Rev Stat Appl       Date:  2019-03       Impact factor: 5.810

4.  Response to reader reaction.

Authors: 
Journal:  Biometrics       Date:  2014-10-29       Impact factor: 2.571

5.  A SMART approach to optimizing delivery of an mHealth intervention among cancer survivors with posttraumatic stress symptoms.

Authors:  Sophia K Smith; Tamara J Somers; Eric Kuhn; Eric Laber; Anthony D Sung; Karen L Syrjala; Bryan Feger; Sarah A Kelleher; Catherine Majestic; Rebecca Gebert; Matthew LeBlanc; Jason E Owen; Allison J Applebaum
Journal:  Contemp Clin Trials       Date:  2021-09-16       Impact factor: 2.226

6.  TARGETED SEQUENTIAL DESIGN FOR TARGETED LEARNING INFERENCE OF THE OPTIMAL TREATMENT RULE AND ITS MEAN REWARD.

Authors:  Antoine Chambaz; Wenjing Zheng; Mark J van der Laan
Journal:  Ann Stat       Date:  2017-12-15       Impact factor: 4.028

7.  Optimal Individualized Treatments in Resource-Limited Settings.

Authors:  Alexander R Luedtke; Mark J van der Laan
Journal:  Int J Biostat       Date:  2016-05-01       Impact factor: 0.968

8.  Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.

Authors:  Eric B Laber; Ying-Qi Zhao; Todd Regh; Marie Davidian; Anastasios Tsiatis; Joseph B Stanford; Donglin Zeng; Rui Song; Michael R Kosorok
Journal:  Stat Med       Date:  2015-10-28       Impact factor: 2.373

9.  Evaluating the Effectiveness of Personalized Medicine With Software.

Authors:  Adam Kapelner; Justin Bleich; Alina Levine; Zachary D Cohen; Robert J DeRubeis; Richard Berk
Journal:  Front Big Data       Date:  2021-05-18

10.  Optimal individualized decision rules using instrumental variable methods.

Authors:  Hongxiang Qiu; Marco Carone; Ekaterina Sadikova; Maria Petukhova; Ronald C Kessler; Alex Luedtke
Journal:  J Am Stat Assoc       Date:  2020-05-12       Impact factor: 4.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.